Irenic Capital Management LP Makes New Investment in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Irenic Capital Management LP purchased a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 133,907 shares of the company's stock, valued at approximately $5,309,000. Acadia Healthcare makes up approximately 0.6% of Irenic Capital Management LP's portfolio, making the stock its 16th largest holding. Irenic Capital Management LP owned 0.14% of Acadia Healthcare at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. J. Goldman & Co LP purchased a new position in Acadia Healthcare in the fourth quarter worth $25,057,000. Gotham Asset Management LLC acquired a new position in Acadia Healthcare during the 4th quarter valued at about $6,243,000. Granahan Investment Management LLC raised its stake in Acadia Healthcare by 190.9% in the fourth quarter. Granahan Investment Management LLC now owns 142,236 shares of the company's stock valued at $5,640,000 after buying an additional 93,346 shares during the last quarter. FORA Capital LLC purchased a new stake in shares of Acadia Healthcare during the fourth quarter worth about $484,000. Finally, Frontier Capital Management Co. LLC acquired a new position in shares of Acadia Healthcare during the fourth quarter valued at about $4,912,000.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. Royal Bank of Canada dropped their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Guggenheim assumed coverage on shares of Acadia Healthcare in a report on Wednesday, April 9th. They set a "buy" rating and a $36.00 price objective on the stock. Barclays reduced their target price on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research note on Wednesday. KeyCorp dropped their price target on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday. Finally, Mizuho decreased their target price on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a report on Wednesday. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $47.94.

Acadia Healthcare Stock Performance

NASDAQ:ACHC traded up $0.51 during trading hours on Friday, reaching $26.15. The company had a trading volume of 2,120,582 shares, compared to its average volume of 1,700,703. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare Company, Inc. has a 1-year low of $20.36 and a 1-year high of $82.41. The business's 50 day moving average price is $26.25 and its 200-day moving average price is $35.83. The firm has a market cap of $2.41 billion, a PE ratio of 8.57, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.05. The firm had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare's revenue for the quarter was up .3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.84 EPS. Research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.